Skip to main content
. 2021 Feb 26;15:871–879. doi: 10.2147/OPTH.S287747

Figure 1.

Figure 1

(A) Pre chemotherapy photograph of a 70 years old male patient having left lower eyelid ulceronodular type sebaceous gland carcinoma. (B) After 3 cycles of neoadjuvant chemotherapy (cis-platinum and 5 FU), showing partial response of chemotherapy.